Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension
Clinical trial NCT02893995 · WITHDRAWN
Trial details
- NCT number
- NCT02893995
- Sponsor
- United Therapeutics
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-01
- Primary completion
- 2018-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.